Cancer and combination exercise training

effect of combination exercise training on some blood factors and biochemical indices in women with breast cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013122115884N1

Enrollment

Registered

2014-05-05

Start date

2008-04-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Axillary tail of breast

Interventions

Intervention 1: 15 weeks combination exercise training including resistance training and walking for exprimental group. Intervention 2: current therapy.

Treatment - Drugs

15 weeks combination exercise training including resistance training and walking for exprimental group

current therapy

Eligibility

Sex/Gender

Female

Age

50 Years to 69 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1 - the current treatments and undergoing hormone therapy with tamoxifen; 2 menopause ; 3- age 50 to 60 years. exclusion criteria : 1-participating in sports or physical activity and weight control in six months; 2 - Other diseases, such as hypertension, heart disease, and thyroid; 3 - Use Supplement; 4 - The experience of menstruation in the past six months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Insulin like growth factors. Timepoint: pre and after intervention. Method of measurement: In serum using by EKM.;Estradiol. Timepoint: pre and after intervention. Method of measurement: In plasma using by ELISA kits.;Progestron. Timepoint: pre and after intervention. Method of measurement: In plasma using byELISA kits.;Metabolic syndrome. Timepoint: pre and after intervention. Method of measurement: By current measurements methods.;Glutation proxidase. Timepoint: pre and after intervention. Method of measurement: In serum using by EKM kits.;Super oxide dismutase. Timepoint: pre and after intervention. Method of measurement: In serum using by EKM kits.	—

Measure

Time frame

Insulin like growth factors. Timepoint: pre and after intervention. Method of measurement: In serum using by EKM.;Estradiol. Timepoint: pre and after intervention. Method of measurement: In plasma using by ELISA kits.;Progestron. Timepoint: pre and after intervention. Method of measurement: In plasma using byELISA kits.;Metabolic syndrome. Timepoint: pre and after intervention. Method of measurement: By current measurements methods.;Glutation proxidase. Timepoint: pre and after intervention. Method of measurement: In serum using by EKM kits.;Super oxide dismutase. Timepoint: pre and after intervention. Method of measurement: In serum using by EKM kits.

—

Secondary

Measure	Time frame
Some IGFs binding Proteins. Timepoint: pre and after intervention. Method of measurement: In serum using by ELISA kits.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Rahmani-Nia

University of Guilan

frahmani2000@yahoo.com+98 13 1669 0685

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026